Treace Medical Concepts, Inc.
TMCI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$55,743 | -$49,527 | -$42,815 | -$20,552 |
| Dep. & Amort. | $8,419 | $5,352 | $2,133 | $685 |
| Deferred Tax | $0 | $0 | $0 | $419 |
| Stock-Based Comp. | $30,603 | $17,352 | $8,111 | $3,409 |
| Change in WC | -$25,433 | -$9,743 | -$5,809 | -$1,330 |
| Other Non-Cash | $4,987 | $1,991 | $7,732 | $176 |
| Operating Cash Flow | -$37,167 | -$34,575 | -$30,648 | -$17,193 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$11,593 | -$11,458 | -$14,838 | -$2,705 |
| Net Acquisitions | $0 | -$20,000 | $61,680 | $0 |
| Inv. Purchases | -$71,579 | -$169,865 | -$63,409 | $0 |
| Inv. Sales/Matur. | $118,547 | $120,024 | $1,729 | $0 |
| Other Inv. Act. | $0 | $0 | -$61,680 | $0 |
| Investing Cash Flow | $35,375 | -$81,299 | -$76,518 | -$2,705 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $19,608 | -$1,788 |
| Stock Issued | $428 | $109,396 | $2,187 | $109,440 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$268 | -$13 | -$989 | $0 |
| Financing Cash Flow | $160 | $109,383 | $20,806 | $107,652 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,632 | -$6,491 | -$86,360 | $87,754 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,982 | $19,473 | $105,833 | $18,079 |
| End Cash | $11,350 | $12,982 | $19,473 | $105,833 |
| Free Cash Flow | -$48,760 | -$46,033 | -$45,486 | -$19,898 |